SCLX — Scilex Holding Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual income statement for Scilex Holding Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	31.3	38	46.7	56.6	30.3
Cost of Revenue
Gross Profit	27.7	27.2	31.1	39.9	19.7
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	79.6	60	152	140	384
Operating Profit	-48.3	-22	-105	-83.4	-353
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-88.4	-23.4	-114	-72.8	-374
Provision for Income Taxes
Net Income After Taxes	-88.4	-23.4	-114	-72.8	-374
Minority Interest
Net Income Before Extraordinary Items
Net Income	-88.4	-23.4	-114	-72.8	-359
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-88.4	-23.4	-167	-72.8	-402
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-19.9	-10.4	-44.9	-21.1	-31.7
Dividends per Share